CA2084273A1 - Method of preventing reocclusion of arteries - Google Patents

Method of preventing reocclusion of arteries

Info

Publication number
CA2084273A1
CA2084273A1 CA002084273A CA2084273A CA2084273A1 CA 2084273 A1 CA2084273 A1 CA 2084273A1 CA 002084273 A CA002084273 A CA 002084273A CA 2084273 A CA2084273 A CA 2084273A CA 2084273 A1 CA2084273 A1 CA 2084273A1
Authority
CA
Canada
Prior art keywords
linolenic acid
acid
gamma
day
dihomo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002084273A
Other languages
English (en)
French (fr)
Inventor
David Frederick Horrobin
John Charles Marshall Stewart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scotia Holdings PLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2084273A1 publication Critical patent/CA2084273A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Control Of Turbines (AREA)
  • Amplifiers (AREA)
  • Glass Compositions (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
  • Semiconductor Lasers (AREA)
  • Drying Of Semiconductors (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA002084273A 1991-12-02 1992-12-01 Method of preventing reocclusion of arteries Abandoned CA2084273A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9125602.4 1991-12-02
GB919125602A GB9125602D0 (en) 1991-12-02 1991-12-02 Method of preventing reocclusion of arteries

Publications (1)

Publication Number Publication Date
CA2084273A1 true CA2084273A1 (en) 1993-06-03

Family

ID=10705559

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002084273A Abandoned CA2084273A1 (en) 1991-12-02 1992-12-01 Method of preventing reocclusion of arteries

Country Status (17)

Country Link
US (2) US5378732A (enExample)
EP (2) EP0676197A3 (enExample)
JP (1) JPH05286854A (enExample)
KR (1) KR930012009A (enExample)
AT (1) ATE133334T1 (enExample)
AU (2) AU657009B2 (enExample)
CA (1) CA2084273A1 (enExample)
DE (1) DE69207885T2 (enExample)
DK (1) DK0551729T3 (enExample)
ES (1) ES2082390T3 (enExample)
GB (1) GB9125602D0 (enExample)
GR (1) GR3019270T3 (enExample)
HK (1) HK131096A (enExample)
NO (1) NO303047B1 (enExample)
NZ (1) NZ245343A (enExample)
TW (1) TW223589B (enExample)
ZA (1) ZA929316B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824644A (en) * 1994-07-07 1998-10-20 G. D. Searle & Co. Method of attenuating arterial stenosis
GB0016045D0 (en) * 2000-06-29 2000-08-23 Laxdale Limited Therapeutic combinations of fatty acids
JP2002047176A (ja) * 2000-08-04 2002-02-12 Idemitsu Technofine Co Ltd ＩｇＥ産生抑制剤
ITMI20012384A1 (it) * 2001-11-12 2003-05-12 Quatex Nv Uso di acidi grassi poliinsaturi per la prevenzione primaria di eventi cardiovascolari maggiori
US7098352B2 (en) * 2001-11-16 2006-08-29 Virtus Nutrition Llc Calcium salt saponification of polyunsaturated oils
CA2436650A1 (en) * 2003-08-06 2005-02-06 Naturia Inc. Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses
EA200602014A1 (ru) * 2004-04-30 2007-08-31 ВИРТУС НЬЮТРИШН ЭлЭлСи Синтез солей одновалентных и двухвалентных металлов полиненасыщенных жирных кислот
CA2675836C (en) * 2007-01-17 2016-10-11 Mochida Pharmaceutical Co., Ltd. Composition for preventing or treating thrombus- or embolus-associated disease

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1240513A (en) * 1968-09-13 1971-07-28 Ono Pharmaceutical Co Poly-unsaturated fatty acid ester composition and its preparation
GB1580444A (en) * 1976-11-04 1980-12-03 Bio Oil Res Pharmaceutical compositions
US4526902A (en) * 1983-10-24 1985-07-02 Century Laboratories, Inc. Combined fatty acid composition for treatment or prophylaxis of thrombo-embolic conditions
JPS60132916A (ja) * 1983-12-21 1985-07-16 Nisshin Oil Mills Ltd:The 血栓症予防食品または医薬品
IT1176916B (it) * 1984-10-10 1987-08-18 Elvira Pistolesi Composizione farmaceutica o dietetica ad elevata attivita' antitrombotica e antiarteriosclerotica
US4920098A (en) * 1986-09-17 1990-04-24 Baxter International Inc. Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic vascular, cardiovascular, and/or thrombotic diseases
US5059622A (en) * 1989-08-29 1991-10-22 Biosyn, Inc. Method for reducing blood pressure levels in hypertensive persons
GB8916734D0 (en) * 1989-07-21 1989-09-06 Efamol Holdings Pharmaceutical and dietary uses of fatty acids

Also Published As

Publication number Publication date
GR3019270T3 (en) 1996-06-30
US5859055A (en) 1999-01-12
EP0676197A2 (en) 1995-10-11
TW223589B (enExample) 1994-05-11
AU680725B2 (en) 1997-08-07
US5378732A (en) 1995-01-03
EP0551729B1 (en) 1996-01-24
NZ245343A (en) 1997-06-24
AU1656395A (en) 1995-06-29
DK0551729T3 (da) 1996-02-12
NO924637D0 (no) 1992-12-01
ES2082390T3 (es) 1996-03-16
AU2968792A (en) 1993-06-03
DE69207885T2 (de) 1996-07-25
JPH05286854A (ja) 1993-11-02
KR930012009A (ko) 1993-07-20
ATE133334T1 (de) 1996-02-15
NO303047B1 (no) 1998-05-25
HK131096A (en) 1996-07-26
EP0676197A3 (en) 1996-09-11
GB9125602D0 (en) 1992-01-29
DE69207885D1 (de) 1996-03-07
AU657009B2 (en) 1995-02-23
EP0551729A1 (en) 1993-07-21
ZA929316B (en) 1993-09-09
NO924637L (no) 1993-06-03

Similar Documents

Publication Publication Date Title
JP5362944B2 (ja) くも膜下出血の予後改善剤
JP5441287B2 (ja) 心血管事象を予防するための必須脂肪酸
US4955878A (en) Kit for preventing or treating arterial dysfunction resulting from angioplasty procedures
US4526902A (en) Combined fatty acid composition for treatment or prophylaxis of thrombo-embolic conditions
CA1261274A (en) Pharmaceutical and dietary compositions
CA1287299C (en) Method and compositions for reducing dysfunction in angioplasty procedures
US20020055539A1 (en) Compositions and methods for treating cardiovascular conditions
CA2569697A1 (en) A pharmaceutical composition and its use
AU762246B2 (en) Method and composition for treatment of inflammatory conditions
JPH06279277A (ja) 照射損傷の治療または予防用組成物
US5378732A (en) Method of reducing the rate of reocclusion of arteries
JP2001517697A (ja) 炎症性腸疾患および過敏性腸症候群を治療するための医薬組成物
JP2574153B2 (ja) ガン治療用薬剤
EP0309086A1 (en) Treatment of male pattern baldness and of unwanted hair growth
US4971804A (en) Water dispersible gemfibrozil compositions
JPH03141224A (ja) 血小板凝集を抑制するための治療法および製剤
KR940003552A (ko) 지방산을 이용한 석회화 예방 및 치료방법
JP6857644B2 (ja) 直腸の炎症性変化の治療用医薬製剤
JP2836206B2 (ja) 炎症性腸疾患用油脂組成物
Shikata et al. The role of topically applied dexamethasone in preventing peritoneal adhesions: experimental and clinical studies
Sutherland Medical treatment of inflammatory bowel disease: new therapies, new drugs
US6720356B2 (en) Magnesium di-potassium EDTA complex and method of administration
WO2005046668A1 (ja) 言語障害予防・治療剤
NZ248475A (en) Fatty acid/heparin intravenous compositions
CA2504280A1 (en) Essential fatty acids in the prevention and/or treatment of depression in patients with coronary heart or artery disease

Legal Events

Date Code Title Description
FZDE Discontinued